MARIJN E DEKKERS

CIK 1216068 · Chief Executive Officer · last filed 2024-08-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$67.86M

Companies

8

Total Filings

87

Lifetime Open-Market Net

-$135.75M

Filer Profile

Reported Address
GENERAL ELECTRIC COMPANY
41 FARNSWORTH STREET
BOSTON, MA 02210
Related Filers
ELECTRIC CO GENERAL — 27 joint filings, latest 2018-04-02
BIOGEN INC. — 4 joint filings, latest 2009-06-05
PAUL M MEISTER — 1 joint filings, latest 2023-06-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted Director 5,901,844 $0.01 $37.2K -$2.27M 8 2024-06-14
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Director 444,609 $44.96 $19.99M -$6.89M 5 2024-06-07
QSI Director 650,000 $0.77 $497.9K $0 2 2022-05-13
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Director $18.07 $0 1 2021-06-14
QTRX Director 11,031 $2.69 $29.7K -$4.63M 10 2021-06-08
GE Director 8,226 $337.12 $2.77M $1.16M 25 2018-04-02
TMO Chief Executive Officer 102,814 $613.78 $63.11M -$123.13M 29 2009-08-18
BIIB Director 6,595 $220.83 $1.46M $0 3 2009-06-05

Recent Filings · Page 3 of 9

87 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-06-08 QTRX Mixed −6,810 -$726.5K EDGAR
2021-01-13 QTRX Mixed -$1.69M EDGAR
2021-01-05 QTRX Grant (A) +2,270 $0 EDGAR
2020-08-11 QTRX Sell (S) −27,619 -$897.3K EDGAR
2020-01-06 QTRX Grant (A) +2,270 $0 EDGAR
2019-08-22 QTRX Sell (S) −89,759 -$1.22M EDGAR
2019-01-04 QTRX Grant (A) +2,270 $0 EDGAR
2018-08-09 QTRX Grant (A) +2,270 $0 EDGAR
2018-07-13 QTRX Mixed +117,378 $600.0K EDGAR
2018-04-02 GE Grant (A) $0 EDGAR
Showing 2130 of 87
Page 3 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.